These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9160515)

  • 1. Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.
    Reed RC; Louis-Wileman V; Cosmai EV; Fang S; Jue DL; Wohlhueter RM; Hunter RL; Lal AA
    Vaccine; 1997 Apr; 15(5):482-8. PubMed ID: 9160515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.
    Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA
    J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine.
    Wang R; Charoenvit Y; Corradin G; Porrozzi R; Hunter RL; Glenn G; Alving CR; Church P; Hoffman SL
    J Immunol; 1995 Mar; 154(6):2784-93. PubMed ID: 7876549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-investigation of the circumsporozoite protein-based induction of sterile immunity against Plasmodium berghei infection.
    Reed RC; Louis-Wileman V; Wells RL; Verheul AF; Hunter RL; Lal AA
    Vaccine; 1996 Jun; 14(8):828-36. PubMed ID: 8817831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites.
    Mauduit M; Grüner AC; Tewari R; Depinay N; Kayibanda M; Chavatte JM; Franetich JF; Crisanti A; Mazier D; Snounou G; Rénia L
    PLoS One; 2009 Nov; 4(11):e7717. PubMed ID: 19890387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
    Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
    Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
    Yang C; Collins WE; Xiao L; Saekhou AM; Reed RC; Nelson CO; Hunter RL; Jue DL; Fang S; Wohlhueter RM; Udhayakumar V; Lal AA
    Vaccine; 1997 Mar; 15(4):377-86. PubMed ID: 9141208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged expression of IFNgamma induced by protective blood-stage immunization against Plasmodium yoelii malaria.
    Patterson PS; Bosshardt SC; Udhayukumar V; Xiao L; Kidd M; Hunter RL; Lal AA
    Vaccine; 1999 Aug; 18(1-2):173-80. PubMed ID: 10501247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.
    Charoenvit Y; Mellouk S; Cole C; Bechara R; Leef MF; Sedegah M; Yuan LF; Robey FA; Beaudoin RL; Hoffman SL
    J Immunol; 1991 Feb; 146(3):1020-5. PubMed ID: 1988490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice.
    Billman ZP; Kas A; Stone BC; Murphy SC
    Malar J; 2016 Apr; 15():238. PubMed ID: 27113469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites.
    Sedegah M; Weiss WW; Hoffman SL
    Parasite Immunol; 2007 Nov; 29(11):559-65. PubMed ID: 17944745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
    Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
    Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.
    Rodrigues MM; Cordey AS; Arreaza G; Corradin G; Romero P; Maryanski JL; Nussenzweig RS; Zavala F
    Int Immunol; 1991 Jun; 3(6):579-85. PubMed ID: 1716146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.
    Yoshida S; Nagumo H; Yokomine T; Araki H; Suzuki A; Matsuoka H
    PLoS One; 2010 Oct; 5(10):e13727. PubMed ID: 21060850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei.
    Weiss WR; Berzofsky JA; Houghten RA; Sedegah M; Hollindale M; Hoffman SL
    J Immunol; 1992 Sep; 149(6):2103-9. PubMed ID: 1517574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active and passive immunization against Plasmodium yoelii sporozoites.
    Charoenvit Y; Sedegah M; Yuan LF; Gross M; Cole C; Bechara R; Leef MF; Robey FA; Lowell GH; Beaudoin RL
    Bull World Health Organ; 1990; 68 Suppl(Suppl):26-32. PubMed ID: 1709834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines.
    Calvo-Calle JM; Moreno A; Eling WM; Nardin EH
    Exp Parasitol; 1994 Nov; 79(3):362-73. PubMed ID: 7957756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.
    Charoenvit Y; Majam VF; Corradin G; Sacci JB; Wang R; Doolan DL; Jones TR; Abot E; Patarroyo ME; Guzman F; Hoffman SL
    Infect Immun; 1999 Nov; 67(11):5604-14. PubMed ID: 10531206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.
    Oliveira-Ferreira J; Miyahira Y; Layton GT; Savage N; Esteban M; Rodriguez D; Rodriguez JR; Nussenzweig RS; Zavala F
    Vaccine; 2000 Mar; 18(17):1863-9. PubMed ID: 10699335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.